Influence of atropine, pirenzepine and cimetidine on nocturnal gastro-intestinal motility and gastric acid secretion
- PMID: 6957981
Influence of atropine, pirenzepine and cimetidine on nocturnal gastro-intestinal motility and gastric acid secretion
Abstract
The present study was performed to investigate the correlation between gastric H-ion-concentration and interdigestive motility (1) under basal conditions and (2) under the influence of pirenzepine, atropine and cimetidine. During the control period 6.5 (DZ1 5, DZ9 12) MMC's per 12-hour periods (69 +/- 7% gastrointestinal MMC's) were recorded. After administration of pirenzepine and the combination of pirenzepine and cimetidine almost exclusively gastrointestinal MMC's could be identified. On the other hand, atropine did not change the gastrointestinal/intestinal MMC ratio, but reduced total number of MMC's significancy (p less than 0.05). Percentage of observation time with antral pH greater than 4 was significantly increased by the combination of pirenzepine and cimetidine, but not by pirenzepine or cimetidine alone nor by atropine. There was a positive correlation between interdigestive cycle-length and percentage of time with antral pH greater than 4. The effect of pirenzepine on interdigestive motility (1) seems not to be mediated by the inhibition of gastric acid and (2) is different from the effect of atropine.
Similar articles
-
Pirenzepine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in peptic ulcer disease and other allied diseases.Drugs. 1985 Aug;30(2):85-126. doi: 10.2165/00003495-198530020-00001. Drugs. 1985. PMID: 3928324 Review.
-
The inhibition of vagal stimulated acid secretion by pirenzepine and cimetidine.Scand J Gastroenterol Suppl. 1982;72:169-71. Scand J Gastroenterol Suppl. 1982. PMID: 6957986
-
Effects of cimetidine and pirenzepine on peroperative electrical vagal stimulation of gastric acid secretion.Scand J Gastroenterol Suppl. 1980;66:95-100. Scand J Gastroenterol Suppl. 1980. PMID: 6941381
-
Interactions of cimetidine and pirenzepine on peptone-stimulated gastric acid secretion in man.Scand J Gastroenterol Suppl. 1980;66:103-14. Scand J Gastroenterol Suppl. 1980. PMID: 6941373 Clinical Trial.
-
[Prophylaxis of acute gastroduodenal lesions in critically ill patients].Acta Gastroenterol Latinoam. 1981;11(4):487-510. Acta Gastroenterol Latinoam. 1981. PMID: 7048831 Review. Spanish.
Cited by
-
Pirenzepine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in peptic ulcer disease and other allied diseases.Drugs. 1985 Aug;30(2):85-126. doi: 10.2165/00003495-198530020-00001. Drugs. 1985. PMID: 3928324 Review.
-
5-Hydroxytryptamine and human small intestinal motility: effect of inhibiting 5-hydroxytryptamine reuptake.Gut. 1994 Apr;35(4):496-500. doi: 10.1136/gut.35.4.496. Gut. 1994. PMID: 8174987 Free PMC article. Clinical Trial.
-
Dissociation of duodenogastric marker reflux and bile salt reflux.Dig Dis Sci. 1985 Aug;30(8):733-8. doi: 10.1007/BF01320486. Dig Dis Sci. 1985. PMID: 4017833 Clinical Trial.
-
Effect of a tricyclic antidepressant on small intestinal motility in health and diarrhea-predominant irritable bowel syndrome.Dig Dis Sci. 1995 Jan;40(1):86-95. doi: 10.1007/BF02063948. Dig Dis Sci. 1995. PMID: 7821126 Clinical Trial.